DCF — YALE NEW HAVEN HOSPITAL
Enterprise Value: $-8.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-8.2B
Enterprise Value
$-2.5B
PV of Cash Flows
$-5.7B
PV of Terminal Value
$-9.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $3.5B | $-539.3M | -15.0% | $-689.5M | $-626.8M |
| Year 2 | $3.7B | $-518.9M | -14.0% | $-673.6M | $-556.7M |
| Year 3 | $3.8B | $-496.8M | -13.0% | $-656.2M | $-493.0M |
| Year 4 | $3.9B | $-492.3M | -13.0% | $-656.5M | $-448.4M |
| Year 5 | $4.0B | $-497.1M | -12.0% | $-666.2M | $-413.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-8.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15695744409202983
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5